Senescent cells exhibit altered expression of numerous genes. Identifying the significance of the changes in gene expression may help advance our understanding of the senescence biology. Here, we report on the consistent and strong upregulation of CST1 expression during cellular senescence, independent of the initial trigger. CST1 expression at both the messenger RNA and protein levels was barely detected in control cells, which included early passage proliferating, quiescent, or immortal human fibroblasts and various human tumor cell lines. Immunoblotting and immunofluorescence cytochemical studies further suggest that CST1 accumulates intracellularly, within vesicular structures. We discuss these results in light of the known function of CST1 as a potent inhibitor of lysosomal cysteine proteases.
A GING in complex multicellular organisms entails distinctive changes in cells and molecules that ultimately compromise the fitness of adult organisms. The cellular and molecular changes that lead to the phenotypes we recognize as aging or senescence comprise both systemic and cellular components (1, 2) . Vascular dysfunction has recently gained considerable attention as a critical element of the aging process (3, 4) . Many features characterize senescence at the cellular and molecular level. Uncovering the specific molecular changes in senescent cells may help to shed light on the biology of senescence.
Numerous studies have suggested that a senescence phenotype can be triggered by various stimuli, including telomere-dependent and -independent mechanisms (5-7). For example, we have shown that expression of oncogenic RasV12 (ras) induces a permanent cell cycle arrest in normal human and primary rodent fibroblasts that is phenotypically indistinguishable from replicative senescence, at least with regard to morphology, p16 expression, and senescenceassociated b-galactosidase activity (SA-b-Gal) histochemical staining (8, 9) . Using ras-induced senescence as a model system, several significant aspects of the senescence biology have been uncovered (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Our group thus continues to utilize this highly reproducible and well-controlled model system as a tool to help understand the senescence biology.
Here, we identified CST1 as a highly induced gene upon oncogene (ras)-mediated senescence of human fibroblasts. CST1 was originally isolated as a neutral salivary cystatin (or cystatin SN) (18) and shown to belong to the cystatin superfamily of endogenous cysteine protease inhibitors (19) . Full-length CST1 was independently purified from human saliva and cloned from submandibular gland tissue as cystatin SA-I (20) . It was shown to be highly expressed in salivary glands as well as in one or two other exocrine glands (21) . Most healthy human tissues, however, express little or no detectable levels of CST1. In vitro studies suggest that it might have potent inhibitory activity toward lysosomal cysteine proteases (20, (22) (23) (24) (25) . Perhaps, due to its low expression level in most normal tissues, little is known about the specific biological role of CST1. In the current study, we identified a unique expression pattern of CST1 using a set of well-established senescence models. We show that CST1 expression is highly associated with cellular senescence, independent of the initial trigger. Our results provide a sound scientific basis upon which the clinical and functional significance of the senescence-associated expression of CST1 can be further explored.
Materials and Methods

Cell Culture and Retroviral Gene Transfer
Human early passage (EP) and diploid IMR-90 fibroblasts (ATCC) were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Invitrogen/GIBCO, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; HyClone) and antibiotics (Invitrogen/GIBCO) as previously described (8, 26) . Oncogenic Ras (H-RasV12) or an empty vector (pBabe-puro) was introduced into EP (Passages 5-7) IMR-90 cells by retroviral gene transfer, as described previously (8, 26) . Briefly, retroviruses were produced in amphotropic Phoenix retrovirus packaging cells (ATCC) and were used to infect target fibroblasts. Stably transduced cell populations were established by selection in puromycin (2.5 mg/mL). These cells will herein be referred to as oncogenic Rasinduced (Ras) senescent and vector control (Vec) cells, respectively. Replicative senescent (RS) cells were established by passaging IMR-90 cells up to ~65 population doublings. Quiescent (Q or d4) cells were generated by plating cells at low density and maintaining them in DMEM containing 0.1% FBS for 4 days. Serum starvation-induced senescent cells were generated by culturing cells in DMEM containing 0.1% FBS for 18-21 days (d18) with media changes twice a week (16) . Radiation-induced senescent cells were generated by g-irradiating (10 Gy) IMR-90 cells (GIR) followed by maintaining cells in DMEM containing 10% FBS for 2 days (16).
RNA Extraction and Analysis
Total RNA was extracted from cells using QIAshredder Mini Spin Columns in combination with an RNeasy Protect Mini Kit (QIAGEN, Germantown, MD) and following the manufacturer's protocols. Total RNA was quantified on a NanoDrop-1000 spectrophotometer (Thermo Scientific, Waltham, MA). For the analysis of CST1 and CST6 messenger RNA (mRNA) expression, we used standard and quantitative (TaqMan) polymerase chain reaction (PCR) following reverse transcription of total RNA, as we have described before (27, 28) . Briefly, RNA was reverse transcribed using the iScript cDNA Synthesis Kit with oligo(dT)-primers (Bio-Rad, Hercules, CA). One tenth of the reaction volume (2 mL) was immediately used for PCR in a final volume of 50 mL. The conditions for standard PCR amplification were as follows: Hot start at 95°C for 3 minutes; followed by 30 cycles at 95°C for 30 seconds, 55°C for 30 seconds, and 72°C for 30 seconds. PCR was terminated by extension for 7 minutes at 72°C. PCR products were resolved by 1.5% agarose gel electrophoresis and stained with ethidium bromide. Template was replaced by nuclease-free water in non-template controls (NT Ctrl), and reverse transcription reactions performed in the absence of iScript served as reverse transcription-negative controls (−RT Ctrl). The oligonucleotide sequences of the primers were as follows: CST1 mRNA, 5′-GCC-CTT-CAC-TTC-GCC-ATC-3′ (upper primer) and 5′-TGG-CCT-GGC-ACA-GAT-CCC-TA-3′ (lower primer); CST6 mRNA, 5′-GTA-CTT-CCT-GAC-GAT-GGA-GAT-G-3′ (upper primer) and 5′-TAG-GAG-CTG-AGA-GGA-GTT-CTG-3′ (lower primer); b 2 -microglobulin (b 2 -m) mRNA, 5′-TAG-CTG-TGC-TCG-CGC-TAC-TC-3′ (upper primer) and 5′-GTC-GGA-TGG-ATG-AAA-CCC-AG-3′ (lower primer); and 18S rRNA (18S), 5′-TCA-AGA-ACG-AAA-GTC-GGA-GG-3′ (upper primer) and 5′-GGA-CAT-CTA-AGG-GCA-TCA-CA-3′ (lower primer).
The thermal cycling conditions for quantitative (realtime) PCR were as described above for conventional PCR, except that TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA) were used. For each amplification reaction, 2 mL of freshly synthesized cDNAs were transferred into 25 mL (final volume) of TaqMan Universal PCR Master Mix containing AmpErase UNG, a 6-FAM-labeled TaqMan probe and specific primers. The TaqMan probe/ primer sets were as follows: CST1 mRNA, Hs00606961_ m1 (for specific sequence information on CST1 PCR primers and probe for TaqMan, see Supplementary Figure S1 ); CST6 mRNA, Hs00154599_m1; and 18S rRNA, Hs99999901_s1. At least three experiments were performed for each TaqMan assay. An experiment consisted of duplicate amplification reactions for each gene product being analyzed. The 18S rRNA was used as an internal control for equal sampling of total RNA from one cell strain to another. No cDNA template (NT) and no reverse transcriptase (RT) were used as negative controls. The cycle threshold number (C t ), at which amplification entered exponential phase, was determined for each PCR using an integrated Step One Plus system (Applied Biosystems). The cycle threshold number was used as an indicator of the relative amount of initial target RNA in each sample. That is, a lower C t indicated a higher starting amount of target mRNA. The comparative C t method was used to calculate the relative abundance of a target transcript with regard to an internal control (18S rRNA). Results are expressed as relative abundance of a specific mRNA between EP-, quiescent-, senescent-, immortal-, and spontaneously tumorigenic fibroblasts and vector-transduced and H-RasV12-transduced cells (fold change ± SEM, for n = 6-8).
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Western Blot Analyses
Most Western blot analyses were carried out using cells grown in the presence of serum (10% FBS). Total cell lysates were prepared in Laemmli buffer after trypsinyzation and washing of the cells as previously described (10) . Precast 10% or 4%-15% Ready-Gels and prestained Kaleidoscope molecular weight standards were from Bio-Rad. Resolved proteins were transferred onto Immobilon-P membranes (Millipore, Billerica, MA). Membranes were blocked using 5% nonfat dry milk in 0.2% (v/v) Tween 20 phosphate-buffered saline and probed with the indicated antibodies. The following polyclonal and monoclonal antibodies (pAb and mAb, respectively) were used: Goat pAb and mouse mAb to human CST1 (AF1285 and MAB1285) and recombinant human and mouse cystatins were all from R&D Systems (Minneapolis, MN); rabbit pAb to human CST6 (28); mouse mAb to p16 INK4A (C20; Delta BioLabs, Gilroy, CA); and mouse mAb to a-tubulin (clone B-5-1-2; Sigma, St. Louis, MO). Horseradish peroxidase-conjugated anti-mouse (Bio-Rad), anti-rabbit, and anti-goat immunoglobulins (Pierce, Rockford, IL) were used as secondary antibodies. The signals were detected using West-Pico SuperSignal (Pierce) chemiluminescence in conjunction with Kodak BioMax MR films (Eastman Kodak Co., Rochester, NY). All Western blot analyses were repeated at least three times independently. Representative data are presented.
Immunohistochemistry
For the analysis of the specificity of the goat pAb and mouse mAb directed against human CST1 (R&D Systems), we used archival normal human submandibular gland and pancreatic tissues as positive and negative controls, respectively (21) . For the immunohistochemical analysis, 4-to 5 mm-thin sections were cut, warmed to 60°C, deparaffinized in xylene, and then rehydrated with graded ethanol. This step was followed by antigen exposure for 20 min in heated antigen retrieval solution and inactivation of endogenous peroxidases by treatment for 20 minutes with 0.3% H 2 O 2 in methanol. The sections were blocked for 20 minutes in normal donkey serum in phosphate-buffered saline (BioGenex, San Ramon, CA) and incubated with goat pAb or mouse mAb to CST1 for 1 hour using an automated stainer (BioGenex I6000 Automated Staining System). Samples were rinsed five times in washing buffer and incubated in secondary antibody (MultiLink-BioGenex Super Sensitive Link-Label IHC Detection System) for 30 minutes. Samples were rinsed three times in wash buffer and then incubated in horseradish peroxidase label (BioGenex) for 15 minutes. Samples were rinsed three times in wash buffer and then incubated in diaminobenzidine (Dako Cytomation Liquid DAB Substrate Chromogen System) for 5 minutes. Samples were rinsed three times in wash buffer and counterstained in hematoxylin (Dako Cytomation Automation Hematoxylin) for two minutes.
Immunofluorescence Cytochemistry
Cells were grown to semi-confluency on glass coverslips or in chamber slides and fixed with 4% parafor maldehyde in phosphate-buffered saline. Intracellular labeling was carried out at room temperature using 0.2% (v/v) Triton X-100-permeabilized cells and a mouse mAb directed against human CST1 (MAB1285, Clone 213139; R&D Systems). The secondary antibody used was an AlexaFluor-488-conjugated affinity-purified goat pAb directed against mouse IgG (H+L) (A-11001; Molecular Probes, Eugene, OR). Nuclei (DNA) were counter labeled with 10 mg/mL 4,6′-diamidino-2-phenylindole (DAPI; Sigma). Coverslips were mounted upside down in SlowFade Antifade reagent (Molecular Probes) on glass slides and results documented using a charge-coupled device camera attached to a Nikon TE300 inverted epifluorescence microscope.
Statistical Analyses
One-way analysis of variance followed by Fisher's least significant difference post hoc test (SPSS, Chicago, IL) was used for comparisons of relative CST1 or CST6 mRNA expression levels (log numbers obtained by TaqMan analyses) in different human cells or in one type of cell following different treatments. Differences with p < .01 (*) or p < .001 (**) were considered statistically significant. All results are expressed as mean ± SEM.
Results and Discussion
Previously, we performed a microarray gene expression analysis of ras-induced senescence to identify gene expression changes accompanying the senescence process in normal human lung IMR-90 fibroblasts (26) . It is anticipated that understanding these gene expression changes will help to shed light on the onset or progression of aging-related pathologies. From this microarray study, we extracted gene expression data for several cystatins, that is, for CST1 to CST8. The complete analysis of cystatin expression on duplicate arrays from vector controls (Vec-1 and Vec-2) and ras-transduced cells (Ras-1 and Ras-2) at Day 6 posttransduction and selection is presented in the Supplementary Figure S2 .
With regard to expression of the different cystatin genes in the normal human diploid IMR-90 fibroblasts, only CST1, CST2, CST3, and CST4 received significant presence calls. This means that these cystatins were either initially detected in control cells only (none), in ras-transduced cells only (CST1, CST2, and CST4), or in both (CST3). The other cystatins (CST5 to 8) received absence calls meaning that their detection signals were not significantly different from those of the sense probesets or background noise.
The absolute signal for CST2 was assessed as absent in vector-transduced cells but increased upon ras transduction to reach a signal-to-log-ratios of 2.3, which corresponds to a 4.9-fold increase in expression in senescent cells when compared with vector controls (Figure 1) . However, the absolute level of expression was still low and would have been difficult to validate by other means such as immunoblotting. We therefore did not pursue the study of this cystatin.
CST3 is expressed by most if not all cells and tissues (see GeneCard for CST3 at: http://www.genecards.org/cgi-bin/ carddisp.pl?gene=CST3&search=cst3). It is thus considered a typical housekeeping-type gene with moderate regulation. The microarray analysis confirmed this, showing moderate and high levels of expression in vector control and ras-transduced cells, respectively. On average, CST3 expression increased 3.5-fold (signal-to-log-ratios = 1.8), and this change was highly significant (p = .000020; Figure 1 ). Nevertheless, we chose not to further analyze this gene.
The absolute signal for CST5 was too low to receive a presence call (too low expression with regard to background).
Nevertheless, it gave a several-fold change (signal-to-logratios = −2 to 3.2) in ras transduced cells when compared with vector-transduced counterparts. However, the change call was independently analyzed as nonsignificant (ie, NC, p = .2). From all the cystatin expression data, those for CST5 exhibited the largest variations (signal-to-log-ratios = 0.6, SD = 2.1; Figure 1 ) and were most likely not just due to background variations. Perhaps, the CST5 mRNA contains some repetitive sequences or has some degree of homology to other, unrelated genes. For the above reasons, we did not pursue analysis of this gene or any other genes giving initial absence calls in both vector control and ras-transduced cells.
CST1 and CST4 were the only two cystatin genes that exhibited very strong (90.5-fold both) and highly significant (p ≤ .000033) induction in ras-transduced cells when compared with vector controls (Figure 1 ). Our microarray data are in good agreement with those of others, who used a different model system and found a 60-fold induction of CST1 gene expression during oncogene-mediated cellular senescence [see (29) ; Supplementary Table 1 ]. In our study, both CST1 and CST4 were induced at similar levels. This is not surprising because the two genes have previously been shown to have >90% sequence homology (30, 31) . This high sequence homology extends into the promoter regions of the two genes (see Supplementary Figure S3 ) (32) , supporting a coregulated pattern of expression of the two genes (21) . Despite this homology, however, the two proteins differ greatly in their inhibitory activity toward lysosomal cysteine proteases, CST1 being a potent and CST4 a poor inhibitor (22, 23, 33) . Because impaired lysosomal protein degradation is considered a key feature of the senescent phenotype and may contribute to various age-related diseases (34-37), we have begun to investigate the potential significance of the enhanced expression of CST1 in senescent cells.
First, we used standard RT-PCR as well as quantitative TaqMan PCR to validate the microarray expression data for CST1. As can be seen from Figure 2 , CST1 expression in ras-transduced fibroblasts was increased close to 60-fold over vector controls (Figure 2A and B, compare Ras and Vec, respectively). This is in good agreement with the Figure 2 . Validation of CST1 expression during ras-mediated senescence of human fibroblasts. Normal human lung IMR-90 fibroblasts were transduced with oncogenic H-RasV12 (Ras) or retroviral vector control (Vec). In some experiments, cells were rendered immortal by cotransducing the adenoviral oncogenes E1A and H-RasV12 (E+R). From this immortal cell population, a spontaneously mutated clone (Mut) emerged that is tumorigenic in scid mice. At Day 6 after transduction and selection, total RNA was isolated, reverse transcribed, and analyzed by standard polymerase chain reaction (PCR) (A) and real-time (TaqMan) PCR (B and C). Results are expressed as relative expression levels (or fold changes) with regard to the expression level of the vector control (= 1.0). The ∆∆C t method was used to normalize data with regard to levels of 18S rRNA, and data were expressed as mean ± SEM for each experiment. Analysis of variance was used for statistical analysis (*p < .01 and **p < .001). CST1, expression of the CST1 mRNA; CST6, expression of the CST6 mRNA; b 2 m, expression of b 2 -microglobulin; −RT Ctrl, control PCR amplification without reverse transcription. Figure 1 . Enhanced (90-fold) expression of CST1 and CST4 upon rasmediated senescence of human fibroblasts. Normal human lung IMR-90 fibroblasts were transduced with oncogenic Ras (H-RasV12) or retroviral vector control. At Day 6 after transduction and selection, total RNA was isolated and processed for gene expression profiling (GPL: U133A). Duplicate experiments (n = 2) were performed, and results are expressed as mean signal-to-log-ratios (SLR) for each transcript species (2 SLR = fold change). Changes in cystatin gene expression with a mean p < .0001 were considered statistically highly significant.
here in replication-and oncogene-induced senescent cells might be linked to the irreversible nature of the cell cycle arrest. The observed weaker induction of CST1 expression after prolonged replication when compared with ras transduction may be mainly due to the fact that RS cells are able to slowly divide, whereas ras-induced senescence exhibits an extremely tight cell cycle arrest. CST6 expression was also significantly enhanced during replicative senescence when compared with EP, proliferating fibroblasts ( Figure 3C , compare RS and EP). Expression of CST6 also slightly increased upon quiescence of the fibroblasts ( Figure 3C , previous microarray data (Figure 1) . The microarray data also indicated that expression of another cystatin, namely CST6, was low or absent in the lung fibroblasts and barely changed upon similar treatment. Thus, CST6 expression could serve as a suitable negative control. Using quantitative TaqMan PCR, we found that CST6 expression actually decreased upon ras-induced senescence ( Figure 2C , compare Vec and Ras). Thus, the CST1 and CST6 genes responded in opposite manner during oncogene (ras)-induced senescence.
Although the oncogene ras alone induces senescence in normal human fibroblasts, coexpression of the adenoviral oncogene E1A and ras leads to immortalization in the same cells. Moreover, we have isolated and characterized a spontaneously mutated clone from E1A+ras-transduced cells that is tumorigenic in scid mice (38) . Interestingly, E1A+ras-immortalized fibroblasts (E+R) and the spontaneously derived mutant clone (Mut) with tumorigenic potential exhibited significantly diminished expression of CST1 when compared with vector control (Figure 2A and B, compare E+R and Mut with Vec). This result suggests that enhanced expression of CST1 is not merely a consequence of the forced ras expression but, rather, is linked to the induction or maintenance of a senescence phenotype in fibroblasts.
We previously identified CST6 as a novel tumor suppressor gene for breast cancer (28) . Our findings have since been confirmed by others and extended to several other cancer types [see (39, 40) and references cited therein]. Expression of CST6 also significantly diminished in E1A+ras-immortalized and spontaneously mutant fibroblasts when compared with vector controls ( Figure 2C , compare E+R and Mut with Vec). Diminished expression of CST6 in fibroblasts upon immortalization and acquisition of a tumorigenic potential is certainly in good agreement with a tumor-suppressing function of CST6.
Ample evidence suggests that a senescence phenotype can be triggered by various stress stimuli (7, 41) . Although ras-induced senescence has served as a valuable model system for studying the senescence biology, it is crucial to compare and validate our findings in other senescence models. We thus investigated whether CST1 expression would also increase under other conditions that trigger a senescent phenotype in fibroblasts.
Normal cells have a limited life span and undergo replicative senescence after a defined number of cell divisions (42) . We thus compared expression of CST1 in IMR-90 fibroblasts at an EP and at RS. In Figure 3A and B, we show that CST1 expression was strongly (~16-fold) induced upon replicative senescence when compared with EP, proliferating fibroblasts. Moreover, CST1 expression significantly diminished in quiescent cells (Q) when compared with EP, proliferating fibroblasts ( Figure 3A and B, compare Q and EP). Because quiescence is a reversible cell cycle arrest, our findings suggest that the enhanced expression of CST1 seen the lower induction of CST1 expression (at both the mRNA and protein levels) during RS when compared with OIS (Ras) is most likely due to the fact that RS cells are able to slowly divide, whereas ras-induced senescence exhibits an extremely tight cell cycle arrest. Expression of the cdk inhibitor p16 INK4A is a well-established marker of human cellular senescence and was used here to help validate the senescence state of the cells (Figure 6 , p16 panel) (8) (9) (10) (11) 13, 14, 16, 17) . We have also performed Western blotting studies of samples from senescent cells after prolonged serum starvation and gamma-irradiation but were barely able to detect CST1, perhaps due to the amount of protein expressed or to the affinity of the antibody (data not shown).
compare Q and EP). These findings, together with the observation that CST6 is not induced upon ras-mediated senescence, indicate that CST6 expression is less tightly associated with an irreversible cell cycle arrest than is CST1 expression.
While short-term (4 days) serum starvation induces quiescence, long-term (14-21 days) serum starvation results in an irreversible cell cycle arrest, induction of p16 INK4a , and SA-b-Gal (16) . Based on the above criteria, it seems that serum starvation-induced senescence is also phenotypically indistinguishable from replicative senescence (16) . To further underscore the importance of CST1 in senescence, we examined its expression in human fibroblasts undergoing prolonged serum starvation. Interestingly, our data show that CST1 mRNA expression gradually increased as the cells entered senescence, that is, at Days 14-18 after initiation of serum starvation ( Figures 4A and B) . Similar results-though less pronounced-were observed for CST6 ( Figure 4C ).
Another way of triggering cellular senescence is the repeated exposure of cells to ultraviolet or gamma radiations (43) . We show here that CST1 expression is strongly enhanced (close to 40-fold) in gamma-radiation-induced senescent human IMR-90 fibroblast when compared with non-irradiated control cells ( Figure 5 , compare GIR and Ctrl). This enhanced expression is not seen for CST6, suggesting again a more selective role for CST1. Taken together, our data suggest that CST1 may play a unique and potentially novel role in cellular senescence.
CST1 is a member of the cystatin superfamily of endogenous protease inhibitors (44) . Cystatins seem to selectively target lysosomal cysteine proteases (19) . We next examined the levels of the CST1 protein in senescent cells. For this, we used two commercially available antibodies, a goat pAb and a mouse mAb, both directed against human CST1. The specificity of these antibodies was verified by immunohistochemistry using salivary gland tissue as positive and pancreatic tissue as negative controls, as this has been reported before (21) . Although we present data for the mAb only (see Supplementary Figure S4 ), both antibodies gave very similar results. In normal human salivary glands, the anti-CST1 mAb (and goat pAb) selectively labeled secretion granules within serous secretory cells and "demi-lunes" and exhibited little or no staining of mucous secretory or excretory duct cells as this has been described before (21) . In the normal human pancreas, the CST1 mAb (and pAb) gave little to no immunostaining, with the exception of some sparse acinar cells that stained strongly for CST1. These results are in good agreement with data from others showing strong expression of the CST1 mRNA in salivary glands and little to no expression in the pancreas (21) . In Figure 6 , we show by Western blotting that senescent fibroblasts, particularly oncogene (ras)-induced senescent fibroblasts, exhibit considerable levels of intracellular CST1 when compared with EP, proliferating, or quiescent fibroblasts. As stated above, Figure 4 . Induced CST1 expression during serum starvation-mediated senescence of human fibroblasts. Normal human lung IMR-90 fibroblasts were analyzed at early passage (EP) and after 4, 14, and 18 days of serum starvation (d4, d14, and d18). Total RNA was extracted and analyzed as described in the legend of Figure 2 . In panel (A), levels of the CST1 transcript in cells undergoing replicative senescence (RS) were compared with those in cells undergoing serum starvation (*p < .01 and **p < .001).
Conclusion
In the present study, we have made the following novel findings that suggest a potentially significant role of the lysosomal cysteine protease inhibitor, CST1, in cellular senescence: (a) Using four different triggers of cellular senescence, we found consistent induction of CST1 gene expression in normal human fibroblasts. (b) This induced expression was tightly associated with an irreversible cell cycle arrest and was not seen in quiescent or proliferating cells. (c) In contrast to CST1, expression of another cystatin (CST6) was induced in prolonged replicative-and serum starvation-induced senescence but not in oncogene (ras)-and gamma-radiation-induced senescence. These findings are among the first to suggest that there might be slightly different signaling pathways leading to or maintaining cellular senescence. (d) Significant amounts of CST1 were detected inside the senescent cells and exhibited vesicular immunofluorescence labeling very similar to that of a wellestablished senescence biomarker, namely SA-b-Gal (46) . SA-b-Gal is now known to be no other enzyme than lysosomal b-D-galactosidase (47) . In contrast to lysosomal b-D-galactosidase, however, which is ubiquitously expressed, CST1 has been shown to have a rather restricted pattern of tissue expression in healthy individuals (21) . This could make it an excellent candidate biomarker of senescent cells in vivo, as baseline staining in most tissues would be minimal for this marker.
Phylogenetically, the CST1 gene seems to have appeared late during evolution and to be present only in Primates (44) . The significance of CST1 expression as a potential senescence marker or effector may thus be limited to this Next, we performed immunofluorescence cytochemical studies of CST1 in senescent fibroblasts using the abovedescribed mAb directed against CST1. In the Supplementary Figure S5 , we show that this antibody is specific for CST1 and does not cross-react with other recombinant cystatins. Using DAPI labeling, we first show typical senescenceassociated heterochromatin foci formation in the nuclei of cells undergoing ras-mediated senescence (Figure 7 , compare Vec and Ras under DAPI). Using the CST1 mAb, we then show strong induction of CST1 expression in the senescent fibroblasts (Figure 7 , compare Vec and Ras under CST1). The staining pattern is vesicular, which suggests that CST1 might accumulate within the secretory and/or endolysosomal compartments. CST1 is a potent inhibitor of endolysosomal cysteine proteases, which suggests that its induction and accumulation in senescent cells might impact on lysosomal proteolysis (34, 35, 45) . Further studies are required to define to what extent CST1 is retained within senescent cells and determine its precise subcellular localization and potential colocalization with endolysosomal marker proteins. Figure 5 . Enhanced CST1 expression in irradiation-induced senescence of human fibroblasts. Normal human lung IMR-90 fibroblasts were gamma-irradiated at 10 Gy and grown for 48 hours before collection. Total RNA was isolated and analyzed as described in the legend of Figure 2 . Experiments were run in quadruplicate assays, and data were expressed as mean ± SD. Controls included omission of reverse transcription and omission of RNA. Ctrl, not irradiated control cells; GIR, gamma-irradiated cells. Figure 6 . Intracellular accumulation of CST1 in senescent human fibroblasts. Total proteins were extracted from vector-transduced (Vec), oncogenic Ras-transduced (Ras), early passage proliferating (EP), replicative senescent (RS), and quiescent (Q) IMR-90 fibroblasts. Cellular proteins (20 mg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by immunoblotting using a polyclonal goat anti-human CST1 antibody. The same samples were also analyzed for levels of the cyclin-dependent kinase-inhibitor p16 INK4a (as an indicator of cell cycle arrest) and a-tubulin (as an internal loading control). biological order. One explanation is that the cellular senescence biology might have some species-specific traits. For example, in rats, another member of the cystatin superfamily, namely T-kininogen (for which there is no human ortholog), has been shown to be strongly induced 4 months before the death of the animals, irrespective of their life span (36, (48) (49) (50) . Moreover, it is generally accepted that in mice, the cellular senescence pathways are also quite different from those in humans: For example, p19 ARF is crucial for senescence of mouse cells, whereas the human ortholog (p14 ARF ) is not (51, 52) .
Further studies are now required to establish the clinical and functional significance of CST1 expression during senescence of human cells and determine whether the protease inhibitory function of CST1 is required for its putative role in cellular senescence.
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